Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 51,600 shares at $44.06 ($2.3M) on 2014-11-25, disclosed to the SEC on 2014-11-26.
Scheduled sale ($2.3M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.06 | 300 | $13K | 0.6% |
| 2 | $44.06 | 1,100 | $48K | 2.1% |
| 3 | $44.07 | 200 | $9K | 0.4% |
| 4 | $44.07 | 300 | $13K | 0.6% |
| 5 | $44.07 | 11,374 | $501K | 22.0% |
| 6 | $44.07 | 35,607 |
| $1.6M |
| 69.0% |
| 7 | $44.08 | 1,064 | $47K | 2.1% |
| 8 | $44.09 | 1,400 | $62K | 2.7% |
| 9 | $44.09 | 255 | $11K | 0.5% |
| Total | $44.07 avg | 51,600 | $2.3M | 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |